香港交易所(00388)于2018年4月24日(周二)发布了《新兴及创新产业公司上市制度》的咨询总结。本次咨询与2017年2月发布的咨询文件的方向大致相同,并进一步细化了“同股不同权”、生物科技公司来港上市以及创新产业公司来港第二上市的要求,下文将概览相关要点。为方便读者,本文中特用蓝色字体显示香港交易所于本轮咨询总结提出的修订。


This communication, which we believe may be of interest to our clients and friends of the firm, is for general information only. It is not a full analysis of the matters presented and should not be relied upon as legal advice. This may be considered attorney advertising in some jurisdictions. Please refer to the firm's privacy notice for further details.